Related Experiment Video
Updated: Jan 24, 2026

Microsurgical Clip Obliteration of Middle Cerebral Aneurysm Using Intraoperative Flow Assessment
Published on: September 25, 2009
Pulmonary artery aneurysms: Preoperative, intraoperative, and postoperative findings
Berhane M Worku1, Paolo de Angelis1, Matthew E Wingo1
1Department of Cardiothoracic Surgery, Weil Cornell Medicine, New York, New York.
Insights
Surgical repair of large pulmonary artery aneurysms (PAAs) in six patients resulted in 0% operative mortality and symptom improvement. This indicates PAA repair is a safe and effective option for select individuals.
Area of Science:
- Cardiovascular Surgery
- Thoracic Surgery
- Vascular Surgery
Background:
- Pulmonary artery aneurysms (PAAs) are rare, potentially lethal cardiovascular conditions.
- PAAs are often associated with congenital heart disorders, infections, vasculitis, pulmonary hypertension, and malignancies.
- Limited data exists due to the rarity, necessitating case series for treatment insights.
Purpose of the Study:
- To describe the surgical experience with large PAAs at a single institution.
- To evaluate the safety and efficacy of surgical PAA repair.
- To highlight outcomes in patients with pulmonary hypertension.
Main Methods:
- Retrospective analysis of clinical data for patients undergoing PAA surgery (2009-2017).
- Surgical repair involved woven Dacron grafts for four patients.
- Concomitant pulmonary valve procedures were performed in five patients.
Main Results:
- Six patients with large PAAs (average size 65.0 mm) underwent surgery.
- Average age at surgery was 59.73 years; 83.3% had hypertension.
- Zero operative and 30-day mortality was observed, with an average hospital stay of 10.5 days.
Conclusions:
- Surgical repair of PAAs demonstrated a 0% postoperative mortality rate.
- All patients experienced symptom improvement following PAA repair.
- PAA repair is a safe and effective treatment option for carefully selected patients.
Background:
Pulmonary artery aneurysms (PAAs) are a rare but potentially lethal cardiovascular pathology. PAAs tend to develop in young patients with no gender discrepancy; they are most often associated with congenital heart disorders but also with systemic infections, vasculitis, pulmonary arterial hypertension, chronic pulmonary embolism, and malignancies. Dissection and rupture carry significant morbidity and mortality, thus patients require careful management, especially those with associated pulmonary hypertension. Given the rarity of this condition, physicians have yet to establish standard treatment guidelines. Most studies published to date are case reports with one or two patients; here, we describe our experience with six cases of large PAAs treated surgically at our institution.
Methods:
We identified and retrospectively analyzed clinical data for patients who underwent surgery for PAAs between 2009 and 2017.
Results:
The average age at surgery was 59.73 years, five patients were females, and 83.3% had baseline hypertension. Systolic murmurs were the most common clinical finding. The average aneurysmal size was 65.0 mm. We repaired the PAA with a woven Dacron graft (22-26 mm) in four patients. We performed concomitant pulmonary valve procedures on five patients: four replacements and one repair. Mean pump and cross-clamp times were 108.5 and 65 minutes. Operative and 30-day mortality was 0%. Average length of stay was 10.5 days.
Conclusions:
Postoperative mortality was 0%; all patients showed improvement of symptoms after surgery. These findings confirm that PAA repair has an acceptable risk profile in select patients.
Related Concept Videos
Peripheral Artery Disease V: Postoperative Nursing Management
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Finding the Center of Gravity
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...

